Migraine in Children Recruiting Phase 4 Trials for Lidocaine (DB00281)

IndicationStatusPhase
DBCOND0116907 (Migraine in Children)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03806595Intranasal Lidocaine in Acute Management of Pediatric Migraine and Migraine-like HeadacheTreatment